CMS Targets 15% Medicare Lab Fee Cuts, Putting DGX and LH Revenue at Risk

3-line summary

• CMS is targeting 15% Medicare lab fee cuts, putting revenue at Quest Diagnostics (DGX) and LabCorp (LH) at risk, according to Investing.com.

This summary is our own processing of the source article; see the source link below for full context.